S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.19 (+2.11%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.75 (+2.84%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.14 (+0.88%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.67 (+2.51%)
PRI   125.75 (-0.04%)
NFLX   271.27 (+1.72%)
BAC   31.42 (+0.71%)
GILD   66.58 (+1.09%)
DIS   131.13 (-0.96%)
S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.19 (+2.11%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.75 (+2.84%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.14 (+0.88%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.67 (+2.51%)
PRI   125.75 (-0.04%)
NFLX   271.27 (+1.72%)
BAC   31.42 (+0.71%)
GILD   66.58 (+1.09%)
DIS   131.13 (-0.96%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Urogen PharmaAptorum GroupSyros PharmaceuticalsDermiraImmunoGen
SymbolNASDAQ:URGNNASDAQ:APMNASDAQ:SYRSNASDAQ:DERMNASDAQ:IMGN
Price Information
Current Price$21.81$15.87$5.66$7.03$2.69
52 Week RangeBuyBuyBuyBuyHold
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyHold
Consensus Price Target$58.71$22.00$14.50$18.71$3.28
% Upside from Price Target169.21% upside38.63% upside156.18% upside166.20% upside21.93% upside
Trade Information
Market Cap$463.49 million$463.29 million$244.45 million$399.84 million$415.92 million
Beta1.14N/A1.611.322.16
Average Volume208,0934,804185,9891,201,7402,984,444
Sales & Book Value
Annual Revenue$1.13 million$380,000.00$2.05 million$42.34 million$53.82 million
Price / Sales403.331,210.05117.179.037.49
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$6.55 per share$1.13 per share$2.34 per share($0.21) per share$0.07 per share
Price / Book3.3314.042.42-33.4838.43
Profitability
Net Income$-75,660,000.00$-14,830,000.00$-62,280,000.00$-221,540,000.00$-168,840,000.00
EPS($4.80)N/A($1.91)($5.24)($1.18)
Trailing P/E RatioN/A0.00N/AN/AN/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-3,137.55%-306.91%-357.97%
Return on Equity (ROE)-53.60%N/A-79.79%-478.29%-573.13%
Return on Assets (ROA)-49.90%N/A-59.60%-53.19%-55.71%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.01%0.15%4.95%N/A
Current Ratio16.14%12.97%8.11%8.42%3.48%
Quick Ratio16.14%12.91%8.11%8.08%3.48%
Ownership Information
Institutional Ownership Percentage70.31%0.04%82.08%94.51%68.06%
Insider Ownership Percentage10.50%N/A14.80%12.40%3.77%
Miscellaneous
Employees703976333296
Shares Outstanding20.90 million28.97 million42.44 million54.40 million149.89 million
Next Earnings Date11/11/2019 (Estimated)N/A11/7/2019 (Estimated)11/6/2019 (Estimated)11/1/2019 (Confirmed)
OptionableOptionableNot OptionableOptionableOptionableOptionable
 Urogen PharmaAptorum GroupSyros PharmaceuticalsDermiraImmunoGen

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel